Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies.

Peterson JF, Baughn LB, Ketterling RP, Pitel BA, Smoley SA, Vasmatzis G, Smadbeck JB, Greipp PT, Mangaonkar AA, Thompson CA, Parikh SA, Chen D, Viswanatha DS.

Blood Adv. 2019 Apr 23;3(8):1298-1302. doi: 10.1182/bloodadvances.2019031450. No abstract available.

2.

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.

Coston T, Pophali P, Vallapureddy R, Lasho TL, Finke CM, Ketterling RP, Carr R, Binder M, Mangaonkar AA, Gangat N, Al-Kali A, Litzow M, Zblewski D, Pardanani A, Tefferi A, Patnaik MM.

Am J Hematol. 2019 Jul;94(7):767-779. doi: 10.1002/ajh.25488. Epub 2019 May 3.

PMID:
30964202
3.

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation.

Patnaik MM, Pophali PA, Lasho TL, Finke CM, Horna P, Ketterling RP, Gangat N, Mangaonkar AA, Pardanani A, Tefferi A.

Haematologica. 2019 Jun;104(6):e236-e239. doi: 10.3324/haematol.2018.208082. Epub 2019 Jan 3. No abstract available.

4.

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.

Vairo FPE, Ferrer A, Cathcart-Rake E, King RL, Howard MT, Viswanatha DS, Klee EW, Mangaonkar AA, Patnaik MM.

Leuk Lymphoma. 2019 May;60(5):1337-1339. doi: 10.1080/10428194.2018.1522443. Epub 2018 Nov 8. No abstract available.

PMID:
30407884
5.

In Reply-Short Telomere Syndromes, Biological Aging, and Hematopoietic Stem Cell Transplantation.

Mangaonkar AA, Patnaik MM.

Mayo Clin Proc. 2018 Nov;93(11):1685-1687. doi: 10.1016/j.mayocp.2018.08.012. No abstract available.

PMID:
30392550
6.

Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target.

Mangaonkar AA, Patnaik MM, Oliver GR, Rao KW, Kaiser-Rogers K, Davila JI, Fadra N, Wehrs RN, Elliott MA, Greipp PT, Halling KC, Van Dyke DL.

Leuk Lymphoma. 2019 Mar;60(3):821-824. doi: 10.1080/10428194.2018.1498492. Epub 2018 Aug 30. No abstract available.

PMID:
30160574
7.

Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients.

Higgins A, Mangaonkar AA, Hefazi M, Viswanatha D, Horna P, Foran J, Gangat N.

Leuk Res. 2018 Sep;72:1-4. doi: 10.1016/j.leukres.2018.07.018. Epub 2018 Jul 21. No abstract available.

PMID:
30055376
8.

Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts.

Mangaonkar AA, Gangat N, Al-Kali A, Elliott MA, Begna KH, Hanson CA, Ketterling RP, Wolanskyj-Spinner AP, Hogan WJ, Litzow MR, Patnaik MM.

Leuk Res. 2018 Aug;71:60-62. doi: 10.1016/j.leukres.2018.07.010. Epub 2018 Jul 11.

PMID:
30015104
9.

Clinical Correlates and Treatment Outcomes for Patients With Short Telomere Syndromes.

Mangaonkar AA, Ferrer A, Pinto E Vairo F, Cousin MA, Kuisle RJ, Klee EW, Kennedy CC, Peters SG, Scott JP, Utz JP, Baqir M, Sekiguchi H, Khan SP, Rodriguez V, Simonetto DA, Kamath PS, Abraham RS, Wylam ME, Patnaik MM.

Mayo Clin Proc. 2018 Jul;93(7):834-839. doi: 10.1016/j.mayocp.2018.05.015.

PMID:
29976374
10.

Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside.

Mangaonkar AA, Patnaik MM.

Mayo Clin Proc. 2018 Jul;93(7):904-916. doi: 10.1016/j.mayocp.2018.03.020. Epub 2018 May 24. Review.

PMID:
29804726
11.

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts.

Mangaonkar AA, Lasho TL, Finke CM, Gangat N, Al-Kali A, Elliott MA, Begna KH, Alkhateeb H, Wolanskyj-Spinner AP, Hanson CA, Ketterling RP, Hogan WJ, Pardanani A, Litzow MR, Tefferi A, Patnaik MM.

Blood Cancer J. 2018 Feb 12;8(2):18. doi: 10.1038/s41408-018-0051-1. No abstract available.

12.

Prognostic risk model for patients with high-risk polycythemia vera and essential thrombocythemia.

Mangaonkar AA, Hoversten KP, Gangat N.

Expert Rev Hematol. 2018 Mar;11(3):247-252. doi: 10.1080/17474086.2018.1426455. Epub 2018 Jan 20. Review.

PMID:
29313725
13.

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.

Haddox CL, Mangaonkar AA, Chen D, Shi M, He R, Oliveira JL, Litzow MR, Al-Kali A, Hogan WJ, Elliott MA.

Blood Cancer J. 2017 Sep 15;7(9):e607. doi: 10.1038/bcj.2017.89. No abstract available.

14.

Patterns of Care and Survival for Elderly Acute Myeloid Leukemia-Challenges and Opportunities.

Mangaonkar AA, Patnaik MM.

Curr Hematol Malig Rep. 2017 Aug;12(4):290-299. doi: 10.1007/s11899-017-0388-8. Review.

PMID:
28567524
15.

Bone marrow fibrosis and metastatic prostate adenocarcinoma.

Mangaonkar AA, Gupta HR, Bera BM, Barmare S.

BMJ Case Rep. 2012 Dec 12;2012. pii: bcr2012007348. doi: 10.1136/bcr-2012-007348.

Supplemental Content

Loading ...
Support Center